APA
El-Metnawy W. H., Mattar M. M., El-Nahass Y. H., Samra M. A., Abdelhamid H. M., Abdlfattah R. M. & Hamed A. R. (20130516). Predictive Value of Pretreatment BCR-ABL(IS) Transcript level on Response to Imatinib Therapy in Egyptian Patients with Chronic Phase Chronic Myeloid Leukemia (CPCML). : International journal of biomedical science : IJBS.
Chicago
El-Metnawy Wafaa H, Mattar Mervat M, El-Nahass Yasser H, Samra Mohamed A, Abdelhamid Hala M, Abdlfattah Raafat M and Hamed Ahmad R. 20130516. Predictive Value of Pretreatment BCR-ABL(IS) Transcript level on Response to Imatinib Therapy in Egyptian Patients with Chronic Phase Chronic Myeloid Leukemia (CPCML). : International journal of biomedical science : IJBS.
Harvard
El-Metnawy W. H., Mattar M. M., El-Nahass Y. H., Samra M. A., Abdelhamid H. M., Abdlfattah R. M. and Hamed A. R. (20130516). Predictive Value of Pretreatment BCR-ABL(IS) Transcript level on Response to Imatinib Therapy in Egyptian Patients with Chronic Phase Chronic Myeloid Leukemia (CPCML). : International journal of biomedical science : IJBS.
MLA
El-Metnawy Wafaa H, Mattar Mervat M, El-Nahass Yasser H, Samra Mohamed A, Abdelhamid Hala M, Abdlfattah Raafat M and Hamed Ahmad R. Predictive Value of Pretreatment BCR-ABL(IS) Transcript level on Response to Imatinib Therapy in Egyptian Patients with Chronic Phase Chronic Myeloid Leukemia (CPCML). : International journal of biomedical science : IJBS. 20130516.